💊 Foundayo (Orforglipron) is approved by the FDA

Eli Lilly's new GLP1 drug has been approved by the FDA

Luckily, it’s not an April Fool’s joke — the FDA has approved Orforglipron, Eli Lilly’s new weight loss pill. It’s now called Foundayo:

We don’t know how pharmaceutical companies come up with their names, but at least “Foundayo” is a bit easier to pronounce than “Orforglipron”.

The first point that sticks out about this release is how incredible the pricing is:

Foundayo, Lilly's second FDA-approved obesity medicine, will be available via LillyDirect^® with free home delivery, starting at $25 per month with commercial coverage and $149 for self-pay

Given how effective Orforglipron is and how easy it will be to take compared to an injection, $149/month is an incredible price.

If you think that price is good, the Medicare Part D price is even better — $50. And of course, for those covered under insurance and/or using a savings plan, the prices are even better.

Injectable GLP1s still produce more weight loss than pill forms, but here’s what Orforglipron has produced in clinical trials (in partic…